Congenital diaphragmatic hernia: prenatal diagnosis, outcome and continuing morbidity in survivors

C L Huddy1, P A Boyd, A R Wilkinson

  • 1Department of Paediatrics, University of Oxford, John Radcliffe Hospital, UK.

British Journal of Obstetrics and Gynaecology
|November 5, 1999
PubMed

Insights

Congenital diaphragmatic hernia (CDH) has high mortality and morbidity, with 56% survival for live-born infants and 61% of survivors experiencing chronic disorders. Prenatal diagnosis and counselling are crucial for managing CDH outcomes.

Area of Science:

  • Medical research
  • Obstetrics and Gynecology
  • Pediatric Surgery

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect with significant implications for infant survival and long-term health.
  • Accurate prenatal diagnosis and understanding of associated morbidities are essential for effective management and parental counselling.

Purpose of the Study:

  • To investigate the accuracy of prenatal diagnosis for congenital diaphragmatic hernia (CDH).
  • To determine the pregnancy outcomes and survival rates for infants with CDH.
  • To assess the long-term morbidity in survivors of CDH to improve prenatal counselling.

Main Methods:

  • A cohort study was conducted involving babies diagnosed with CDH between January 1991 and December 1996.
  • Data on prenatal diagnosis, associated anomalies, pregnancy outcomes, and infant health were collected from hospital records and physician reports.
  • Key outcomes measured included the accuracy of prenatal diagnosis, survival rates, and the presence of ongoing morbidity in survivors.

Main Results:

  • Of 35 pregnancies with CDH, 9 were not diagnosed prenatally. Isolated CDH had a high rate of termination or death (12/22).
  • Overall survival for infants born alive with CDH was 56% (13/23).
  • A significant proportion of survivors (61%) experienced chronic health issues, including respiratory problems, developmental delay, and feeding difficulties.

Conclusions:

  • Congenital diaphragmatic hernia (CDH) is associated with substantial mortality and morbidity, even with advances in neonatology.
  • The study highlights the need for comprehensive prenatal diagnosis and counselling that accurately reflects the risks and long-term challenges of CDH.
  • Improved understanding of CDH outcomes is vital for supporting affected families.
Abstract

Related Concept Videos

Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...